Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis. 1998

P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
Multiple Sclerosis Centre Nijmegen, The Netherlands.

We investigated whether cerebrospinal fluid (CSF) analysis may differentiate between relapsing-remitting (RR) and secondary progressive (SP) multiple sclerosis (MS). In 17 RR and 16 SP patients we determined: albumine CSF/PB ratio; mononuclear cell (MNC) number, CD4+, CD8+, and B1+ subsets, CD4+/CD8+ ratio; IgG, IgG index, IgM, IgM index, complement components C3 and C4, and C3 and C4 indexes; myelin basic protein; neuron-specific enolase (NSE); S100; and lactate. For each parameter the statistical distance was calculated. Then, using linear discriminant analysis, we computed a discriminant score, including only variables with a P value less than or equal to 0.15: albumin CSF/PB ratio, MNC number, IgM, IgM index, C3, C4, NSE, S100, and lactate. The discriminant score allocated all 17 RR patients to the RR group and 15 of 16 SP patients to the SP group. We conclude that RR and SP MS patients differ with respect to CSF profile and that in individual patients a composite CSF score may differentiate between RR and SP MS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016002 Discriminant Analysis A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis. Analyses, Discriminant,Analysis, Discriminant,Discriminant Analyses

Related Publications

P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
October 1997, Journal of neurology, neurosurgery, and psychiatry,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
January 2019, Cells,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
December 2001, Clinical neurology and neurosurgery,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
August 2010, PloS one,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
August 2022, Journal of the neurological sciences,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
January 2002, International journal of psychiatry in medicine,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
June 2023, Multiple sclerosis and related disorders,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
May 2012, Nature reviews. Neurology,
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
June 2007, Multiple sclerosis (Houndmills, Basingstoke, England),
P J Jongen, and S Floris, and W H Doesburg, and W A Lemmens, and O R Hommes, and K J Lamers
January 2013, PloS one,
Copied contents to your clipboard!